Elder Pharmaceuticals trades jubilantly on eyeing to sell overseas subsidiaries

24 Sep 2015 Evaluate

Elder Pharmaceuticals is currently trading at Rs. 114.90, up by 14.05 points or 13.93% from its previous closing of Rs. 100.85 on the BSE.

The scrip opened at Rs. 107.00 and has touched a high and low of Rs. 117.40 and Rs. 106.90 respectively. So far 160753 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 197.50 on 24-Sep-2014 and a 52 week low of Rs. 66.65 on 10-Jun-2015.

Last one week high and low of the scrip stood at Rs. 117.40 and Rs. 96.00 respectively. The current market cap of the company is Rs. 207.11 crore.

The promoters holding in the company stood at 25.33% while Institutions and Non-Institutions held 25.63% and 49.04% respectively.

Elder Pharmaceuticals is mulling options to sell its overseas subsidiaries. A meeting of company’s board will be held on September 28 to consider the proposal for sale of step down overseas subsidiaries. The company is in the process of restructuring as a whole as it is facing a severe financial crunch. It is also in an advanced stage of discussions with prospective lenders.

Elder Pharmaceuticals has around six manufacturing units in India, all as per international standards. Post increasing its stake in Elder Biomeda AD and Neutrahealth PLC, EPL also has access to the manufacturing units of these companies in Bulgaria and Birmingham, UK respectively coupled with distribution network and brands of the same.

 

Peers
Company Name CMP
Sun Pharma Inds. 1508.40
Dr. Reddys Lab 6332.85
Cipla 1424.40
Zydus Lifesciences 992.00
Lupin 1663.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.